Dosing & Uses
Clostridioides difficile Infection
Pending FDA approval for prevention of Clostridioides difficile infection recurrence
Next:
Pharmacology
Mechanism of Action
Microbiota-based live biotherapeutic delivered orally to provide a broad consortium of diverse microbes to the gut to reduce recurrent C difficile infection after antibiotic treatment
Previous
Next:
Images
No images available for this drug.
Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
